Documente Academic
Documente Profesional
Documente Cultură
A pharmaceutical company require RM15 million capital investment to expand its current
production and R&D facilities. There are two options to finance this expansion and these are: (1)
RM15 million issuance of common share that will cost the company 12 percent from the amount
raised. The expected cost of equity is at 25%; and (2) RM15 million of long-term debt with
issuance cost is 3 percent and the expected cost of debt is at 10 percent. The tax rate is 22%.
Determine the optimal capital structure based on you own assumption with respect to the
equity/debt ratio.
The earning per share are expected to grow 6 percent per year after year 4, and the net capital
expenditures are expected to decline 50 percent after year 4. Sonata currently has a beta of 1.5 and
no debt or working capital needs but expects its beta to drop to 1 after year 4. The debt ratio will
remain at 0 percent. The Treasury Bond rate is 7 percent and market risk premium is 5.5 percent.
i. Estimate the terminal value of equity per share
ii. Estimate the value per share today
You have been asked to do a discounted cash flow valuation of a firm and have been given the
following partial inputs to the valuation
Year 1 2 3 4
Growth Rate 20% 20% 20% 5%
EBIT(1-t) 100 120 144 151.2